Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K23HL148545 | U.S. NIH Grant/Contract | View source | |
| 2025P010357 | Other Identifier | Emory IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
| University of Utah | OTHER |
Not provided
Not provided
Not provided
Not provided
This project aims to adapt a computer-interface telephonic interactive voice response system that monitors symptoms and provides real-time, self-management coaching messages based on heart failure patient-reported outcomes.
Keeping heart failure (HF) patients at home with a low symptom burden after hospital discharge is challenging. HF patients may suffer worsening symptoms over time without seeking medical advice leading to poor quality of life and readmission to the hospital. Evidence shows that delay in HF symptom recognition and poor self-management are associated with unplanned HF-related emergency department (ED) visits and rehospitalizations. Clinical trials aimed at preventing rehospitalization using telemonitoring of physical changes, such as daily weights, have shown limited utility.
Understanding patients' experiences of HF symptoms and engagement in appropriate self-management are key to maintaining disease stability. Cancer studies have shown that symptom burden can be effectively decreased using automated home monitoring and self-management coaching. A recent cancer study has demonstrated that patients receiving cancer chemotherapy achieved a 40% reduction in symptoms using Symptom Care at Home (SCH), a telephone-computer interface interactive voice response (IVR) system pairing patient-reported symptoms with automated real-time self-management coaching. While a few HF studies have used interventions that monitored symptoms, no studies have tested a system that monitors and provides real-time self-management coaching tailored to specific patient-reported outcomes (PRO). The objective of this study is to adapt the SCH system to HF and conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and preliminary efficacy of the Symptom Care at Home - Heart Failure (SCH-HF) system.
Participants are randomized to receive usual care consisting of automated daily monitoring, or to receive the intervention, which includes automated daily monitoring and real-time self-management coaching.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Symptom Care at Home with Coaching Messages | Experimental | Participants randomized to automated daily monitoring and real-time self-management coaching. |
|
| Usual Care | Active Comparator | Participants randomized to automated daily monitoring only. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Coaching Messages | Behavioral | Participants receive real-time self-management coaching messages based on the severity of their symptoms. When participants call, the IVR system will ask them about each of the selected symptoms, and the patient will report symptom presence and severity numerically with the touch-tone keypad. |
| Measure | Description | Time Frame |
|---|---|---|
| Self-Care of Heart Failure Index (SCHFI) Score | The Self-Care of Heart Failure Index, version 7.2, is a 29-item instrument with separate scales assessing self-care maintenance, symptom perception, and self-care management. Responses to items are given on a 5-point scale. Scores for each of the three scales are summed and standardized with scores ranging from 0 to 100. Higher scores indicate better self-care, with scores of 70 or higher indicating adequate levels of heart failure self-care. | Baseline (at the time of hospital discharge, pre-intervention), Day 30 (post-intervention) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of eligible patients recruited | Feasibility is determined by the number of eligible patients who enroll in the study. | Baseline (at the time of hospital discharge, pre-intervention) |
| Number of participants using the intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Re-hospitalized | The re-hospitalization rate will be an exploratory endpoint between study arms. | Up to 30 days after hospital discharge |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Youjeong Kang, PhD | Emory University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Emory University Hospital Midtown | Atlanta | Georgia | 30308 | United States | ||
| Emory Clinic |
De-identified data will be made available for sharing with other researchers.
Data will be made available for sharing following publication of findings from this study.
Researchers who want to share de-identified data from this study must complete a data use agreement. Those wanting to share data from this study should contact Dr. Kang at youjeong.kang@emory.edu.
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Dec 16, 2025 | May 22, 2026 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D012816 | Signs and Symptoms |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Automated Daily Monitoring | Behavioral | Participants report daily symptoms and symptom severity. There are three categories of severity based on a numeric scale of 1 to 3 for mild symptoms, 4 to 7 for moderate symptoms, and 8 to 10 for severe symptoms. |
|
Feasibility is determined by the number of participants who complete the daily monitoring reports.
| Up to Day 30 (post-intervention) |
| Days on Study | Feasibility is determined by the number of days that participants remain in the study. | Up to Day 30 (post-intervention) |
| Satisfaction with Phone Calls | Acceptability is assessed using a 10-point Likert scale asking participants how satisfied they were with the phone calls. Responses are given such that 10 means the participant was very satisfied and 1 means they were not satisfied at all. | Day 30 (post-intervention) |
| Atlanta |
| Georgia |
| 30322 |
| United States |
| Emory University Hospital | Atlanta | Georgia | 30322 | United States |
| University of Utah Health | Salt Lake City | Utah | 84112 | United States |